Shopping Cart 0
Cart Subtotal
AED 0

Global Carotid Artery Disease Market Research Report Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 16332

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 22938

Details

Global Carotid Artery Disease Market: Information by Diagnosis (Computed Tomography Angiography, Carotid Ultrasound, & Magnetic Resonance Angiography), Treatment (Medications & Surgical Procedures), & End User (Hospitals & Clinics)-Forecast till 2023

Market analysis

Carotid artery disease otherwise called carotid artery stenosis happens when the fats stores (plaques) stop up veins that convey blood to the cerebrum and head (carotid arteries). The blockage builds the danger of stroke, a therapeutic crisis that happens when the blood supply to the cerebrum or brain is hindered or truly diminished. The carotid artery disease market is relied upon to observe huge development attributable to the ascent in cigarette smoking. Other key factors, for example, rising fat blood levels among the populace, expanding geriatric populace, the developing predominance of diabetes, expanding obesity, a growing number of patients with hypertension, and inactive way of life are contributing towards the development of the market. The global carotid artery disease market is projected to register a growth rate of CAGR of 4.1% for reaching the valuation of USD 11,612.16 million until the year 2023.

Market segmentation

The global carotid artery disease market is categorized on the basis of its treatment and diagnosis, end-user and regional demand. Based on its treatment & diagnosis, the market is categorized into treatment and diagnosis. The treatment section is divided into surgical procedures and medications. The medications section is further segmented into antiplatelet drugs, antihypertensive drugs, and cholesterol-lowering statins. The surgical procedures are section is again segmented into carotid artery angioplasty & stenting, carotid artery bypass, and carotid endarterectomy. Again, on the basis of its end user, the market is segmented into ambulatory surgical centers, hospital & clinics, pharmacies, and others.

Regional analysis

Geographically, the global carotid artery disease market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Silk Road Medical, Inc., Abbott, Medtronic, Stryker Corporation, Cardinal Health, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Becton, Dickinson and Company, Terumo Corporation, Hitachi, among others are some of the major players in the global carotid artery disease market.

READ MORE

Table Of Content

Scope

Table of Contents:

1 Executive Summary

2 Market Introduction

2.1 Scope of Study

2.2 Research Objective

2.3 List of Assumptions

3 Research process

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Geriatric Population

4.2.2 Increasing Adoption of Unhealthy Lifestyle

4.2.3 Popularity of Over-the-Counter (OTD) Drugs

4.3 Restraints

4.4 High Cost of Diagnostics and Surgeries

4.5 Stringent Government Regulations

4.6 Opportunities

4.7 Entering Untapped Markets

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D and Product Development

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Monitoring

5.2 Porter's Five Forces Analysis

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Buyers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Investment Opportunity Analysis

6 Global Carotid Artery Disease Market by Treatment & Diagnosis

6.1 Introduction

6.2 Treatment

6.3 Diagnosis

7 Global Carotid Artery Disease Market by End User

7.1 Introduction

7.2 Hospital & Clinics

7.3 Ambulatory Surgical Centers

7.4 Pharmacies

8 Global Carotid Artery Disease Market by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 UK

8.3.1.3 France

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

9 Competitive Landscape

9.1 Introduction

9.2 Key developments

10 Company Profiles

10.1 W. L. Gore & Associates, Inc.

10.1.1 Company Overview

10.1.2 Financial Overview

10.1.3 Products/Services Offered

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.1.6 Key Strategies

10.2 Becton, Dickinson and Company

10.2.1 Company Overview

10.2.2 Financial Overview

10.2.3 Products/Services Offered

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.2.6 Key Strategies

10.3 Terumo Corporation

10.3.1 Company Overview

10.3.2 Financial Overview

10.3.3 Products/Services Offered

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.3.6 Key Strategies

10.4 Hitachi, Ltd

10.4.1 Company Overview

10.4.2 Financial Overview

10.4.3 Products/Services Offered

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.4.6 Key Strategies

10.5 Silk Road Medical, Inc

10.5.1 Company Overview

10.5.2 Financial Overview

10.5.3 Products/Services Offered

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.5.6 Key Strategies

10.6 Abbott

10.6.1 Company Overview

10.6.2 Financial Overview

10.6.3 Products/Services Offered

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.6.6 Key Strategies

10.7 Medtronic

10.7.1 Company Overview

10.7.2 Financial Overview

10.7.3 Products/Services Offered

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.7.6 Key Strategies

10.8 Stryker Corporation

10.8.1 Company Overview

10.8.2 Financial Overview

10.8.3 Products/Services Offered

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.8.6 Key Strategies

10.9 Cardinal Health

10.9.1 Company Overview

10.9.2 Financial Overview

10.9.3 Products/Services Offered

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.9.6 Key Strategies

10.1 Boston Scientific Corporation

10.10.1 Company Overview

10.10.2 Financial Overview

10.10.3 Products/Services Offered

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.10.6 Key Strategies

11 Appendix

11.1 References

11.2 Related Reports


List Of Figure

List of Figures:

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL CAROTID ARTERY DISEASE MARKET: STRUCTURE

FIGURE 3 RESEARCH PROCESS

FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE CAROTID ARTERY DISEASE MARKET

FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CAROTID ARTERY DISEASE MARKET

FIGURE 7 PORTER'S FIVE FORCE ANALYSIS: GLOBAL CAROTID ARTERY DISEASE MARKET

FIGURE 8 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2017 & 2023 (USD MILLION)

FIGURE 10 GLOBAL CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 11 AMERICAS: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 12 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 13 EUROPE: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 14 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 15 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 16 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 17 CATEGORY WISE SHARE OF KEY DEVELOPMENTS


List Of Table

List of Tables:

TABLE 1 LIST OF ASSUMPTIONS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 4 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 5 GLOBAL CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 6 GLOBAL CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 7 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR TREATMENT, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 8 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR DIAGNOSIS, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 9 GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 10 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 11 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION,

2015 TO 2023 (USD MILLION)

TABLE 12 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR PHARMACIES, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 13 GLOBAL CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 14 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 15 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURES)

TABLE 16 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 17 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 18 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 19 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 20 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 21 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 22 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 23 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 24 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 25 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 26 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 27 US: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 28 US: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 29 US: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 30 US: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 31 US: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 32 CANADA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 33 CANADA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 34 CANADA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 35 CANADA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 36 CANADA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 37 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 38 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 39 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 40 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 41 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 42 EUROPE: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 43 EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURES)

TABLE 44 EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 45 EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 46 EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 47 EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 48 EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 49 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 50 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 51 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 52 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 53 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 54 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 55 GERMANY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 56 GERMANY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 57 GERMANY: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 58 GERMANY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 59 GERMANY: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 60 UK: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 61 UK: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 62 UK: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 63 UK: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 64 UK: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 65 FRANCE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 66 FRANCE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 67 FRANCE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 68 FRANCE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 69 FRANCE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 70 ITALY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 71 ITALY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 72 ITALY: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 73 ITALY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 74 ITALY: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 75 SPAIN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 76 SPAIN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 77 SPAIN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 78 SPAIN: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 79 SPAIN: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 80 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS,

2015 TO 2023 (USD MILLION) 70

TABLE 81 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 82 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 83 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 84 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 85 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 86 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 87 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 88 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 89 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 90 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 91 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURES)

TABLE 92 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 93 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 94 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 95 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 96 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 97 JAPAN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 98 JAPAN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 99 JAPAN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 100 JAPAN: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 101 JAPAN: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 102 CHINA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 103 CHINA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 104 CHINA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 105 CHINA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 106 CHINA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 107 INDIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 108 INDIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 109 INDIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 110 INDIA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 111 INDIA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 112 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 113 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 114 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 115 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 116 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 117 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 118 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 119 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 120 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 121 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 122 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 123 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 124 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 125 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 126 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 127 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 128 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURE)

TABLE 129 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 130 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 131 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 132 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 133 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 134 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 135 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 136 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 137 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 138 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 139 AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 140 AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 141 AFRICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 142 AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 143 AFRICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 144 MAJOR MANUFACTURERS IN THE GLOBAL CAROTID ARTERY DISEASE MARKET

TABLE 145 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Silk Road Medical, Inc., Abbott, Medtronic, Stryker Corporation, Cardinal Health, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Becton, Dickinson and Company, Terumo Corporation, Hitachi

Global Carotid Artery Disease Market: Information by Diagnosis (Computed Tomography Angiography, Carotid Ultrasound, & Magnetic Resonance Angiography), Treatment (Medications & Surgical Procedures), & End User (Hospitals & Clinics)-Forecast till 2023

Market analysis

Carotid artery disease otherwise called carotid artery stenosis happens when the fats stores (plaques) stop up veins that convey blood to the cerebrum and head (carotid arteries). The blockage builds the danger of stroke, a therapeutic crisis that happens when the blood supply to the cerebrum or brain is hindered or truly diminished. The carotid artery disease market is relied upon to observe huge development attributable to the ascent in cigarette smoking. Other key factors, for example, rising fat blood levels among the populace, expanding geriatric populace, the developing predominance of diabetes, expanding obesity, a growing number of patients with hypertension, and inactive way of life are contributing towards the development of the market. The global carotid artery disease market is projected to register a growth rate of CAGR of 4.1% for reaching the valuation of USD 11,612.16 million until the year 2023.

Market segmentation

The global carotid artery disease market is categorized on the basis of its treatment and diagnosis, end-user and regional demand. Based on its treatment & diagnosis, the market is categorized into treatment and diagnosis. The treatment section is divided into surgical procedures and medications. The medications section is further segmented into antiplatelet drugs, antihypertensive drugs, and cholesterol-lowering statins. The surgical procedures are section is again segmented into carotid artery angioplasty & stenting, carotid artery bypass, and carotid endarterectomy. Again, on the basis of its end user, the market is segmented into ambulatory surgical centers, hospital & clinics, pharmacies, and others.

Regional analysis

Geographically, the global carotid artery disease market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Silk Road Medical, Inc., Abbott, Medtronic, Stryker Corporation, Cardinal Health, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Becton, Dickinson and Company, Terumo Corporation, Hitachi, among others are some of the major players in the global carotid artery disease market.

READ MORE

Scope

Table of Contents:

1 Executive Summary

2 Market Introduction

2.1 Scope of Study

2.2 Research Objective

2.3 List of Assumptions

3 Research process

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Geriatric Population

4.2.2 Increasing Adoption of Unhealthy Lifestyle

4.2.3 Popularity of Over-the-Counter (OTD) Drugs

4.3 Restraints

4.4 High Cost of Diagnostics and Surgeries

4.5 Stringent Government Regulations

4.6 Opportunities

4.7 Entering Untapped Markets

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D and Product Development

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Monitoring

5.2 Porter's Five Forces Analysis

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Buyers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Investment Opportunity Analysis

6 Global Carotid Artery Disease Market by Treatment & Diagnosis

6.1 Introduction

6.2 Treatment

6.3 Diagnosis

7 Global Carotid Artery Disease Market by End User

7.1 Introduction

7.2 Hospital & Clinics

7.3 Ambulatory Surgical Centers

7.4 Pharmacies

8 Global Carotid Artery Disease Market by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 UK

8.3.1.3 France

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

9 Competitive Landscape

9.1 Introduction

9.2 Key developments

10 Company Profiles

10.1 W. L. Gore & Associates, Inc.

10.1.1 Company Overview

10.1.2 Financial Overview

10.1.3 Products/Services Offered

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.1.6 Key Strategies

10.2 Becton, Dickinson and Company

10.2.1 Company Overview

10.2.2 Financial Overview

10.2.3 Products/Services Offered

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.2.6 Key Strategies

10.3 Terumo Corporation

10.3.1 Company Overview

10.3.2 Financial Overview

10.3.3 Products/Services Offered

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.3.6 Key Strategies

10.4 Hitachi, Ltd

10.4.1 Company Overview

10.4.2 Financial Overview

10.4.3 Products/Services Offered

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.4.6 Key Strategies

10.5 Silk Road Medical, Inc

10.5.1 Company Overview

10.5.2 Financial Overview

10.5.3 Products/Services Offered

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.5.6 Key Strategies

10.6 Abbott

10.6.1 Company Overview

10.6.2 Financial Overview

10.6.3 Products/Services Offered

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.6.6 Key Strategies

10.7 Medtronic

10.7.1 Company Overview

10.7.2 Financial Overview

10.7.3 Products/Services Offered

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.7.6 Key Strategies

10.8 Stryker Corporation

10.8.1 Company Overview

10.8.2 Financial Overview

10.8.3 Products/Services Offered

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.8.6 Key Strategies

10.9 Cardinal Health

10.9.1 Company Overview

10.9.2 Financial Overview

10.9.3 Products/Services Offered

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.9.6 Key Strategies

10.1 Boston Scientific Corporation

10.10.1 Company Overview

10.10.2 Financial Overview

10.10.3 Products/Services Offered

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.10.6 Key Strategies

11 Appendix

11.1 References

11.2 Related Reports


List Of Figure

List of Figures:

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL CAROTID ARTERY DISEASE MARKET: STRUCTURE

FIGURE 3 RESEARCH PROCESS

FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE CAROTID ARTERY DISEASE MARKET

FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CAROTID ARTERY DISEASE MARKET

FIGURE 7 PORTER'S FIVE FORCE ANALYSIS: GLOBAL CAROTID ARTERY DISEASE MARKET

FIGURE 8 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2017 & 2023 (USD MILLION)

FIGURE 10 GLOBAL CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 11 AMERICAS: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 12 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 13 EUROPE: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 14 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 15 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 16 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 17 CATEGORY WISE SHARE OF KEY DEVELOPMENTS


List Of Table

List of Tables:

TABLE 1 LIST OF ASSUMPTIONS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 4 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 5 GLOBAL CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 6 GLOBAL CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 7 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR TREATMENT, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 8 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR DIAGNOSIS, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 9 GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 10 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 11 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION,

2015 TO 2023 (USD MILLION)

TABLE 12 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR PHARMACIES, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 13 GLOBAL CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 14 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 15 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURES)

TABLE 16 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 17 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 18 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 19 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 20 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 21 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 22 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 23 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 24 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 25 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 26 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 27 US: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 28 US: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 29 US: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 30 US: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 31 US: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 32 CANADA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 33 CANADA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 34 CANADA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 35 CANADA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 36 CANADA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 37 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 38 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 39 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 40 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 41 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 42 EUROPE: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 43 EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURES)

TABLE 44 EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 45 EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 46 EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 47 EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 48 EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 49 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 50 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 51 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 52 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 53 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 54 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 55 GERMANY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 56 GERMANY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 57 GERMANY: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 58 GERMANY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 59 GERMANY: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 60 UK: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 61 UK: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 62 UK: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 63 UK: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 64 UK: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 65 FRANCE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 66 FRANCE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 67 FRANCE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 68 FRANCE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 69 FRANCE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 70 ITALY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 71 ITALY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 72 ITALY: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 73 ITALY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 74 ITALY: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 75 SPAIN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 76 SPAIN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 77 SPAIN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 78 SPAIN: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 79 SPAIN: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 80 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS,

2015 TO 2023 (USD MILLION) 70

TABLE 81 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 82 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 83 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 84 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 85 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 86 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 87 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 88 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 89 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 90 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 91 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURES)

TABLE 92 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 93 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 94 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 95 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 96 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 97 JAPAN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 98 JAPAN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 99 JAPAN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 100 JAPAN: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 101 JAPAN: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 102 CHINA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 103 CHINA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 104 CHINA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 105 CHINA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 106 CHINA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 107 INDIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 108 INDIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 109 INDIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 110 INDIA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 111 INDIA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 112 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 113 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 114 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 115 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 116 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 117 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 118 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 119 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 120 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 121 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 122 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 123 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 124 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 125 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 126 REST OF ASIA PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 127 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY REGION, 2015 TO 2023 (USD MILLION)

TABLE 128 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2015 TO 2023 (PROCEDURE)

TABLE 129 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 130 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 131 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 132 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 133 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 134 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 135 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 136 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 137 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 138 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 139 AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2015 TO 2023 (USD MILLION)

TABLE 140 AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2015 TO 2023 (USD MILLION)

TABLE 141 AFRICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2015 TO 2023 (USD MILLION)

TABLE 142 AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2015 TO 2023 (USD MILLION)

TABLE 143 AFRICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2015 TO 2023 (USD MILLION)

TABLE 144 MAJOR MANUFACTURERS IN THE GLOBAL CAROTID ARTERY DISEASE MARKET

TABLE 145 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Silk Road Medical, Inc., Abbott, Medtronic, Stryker Corporation, Cardinal Health, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Becton, Dickinson and Company, Terumo Corporation, Hitachi